Skip to main content
Top
Published in: Journal of Orthopaedic Science 5/2013

01-09-2013 | Case Report

Early diagnosis of impending femoral insufficiency fractures by use of MRI: case report and review of the literature

Authors: Sang-Ho Cheon, Chang-Wug Oh, Jung-Yup Lee, Jae-Hyuck Yi, Hwan-Seong Cho, Jong-Keon Oh, Kyu-Hyun Yang, Gu-Hee Jung

Published in: Journal of Orthopaedic Science | Issue 5/2013

Login to get access

Excerpt

Bisphosphonate (BSP) therapy has been widely used for management of osteoporosis, and has been shown to reduce the risk of vertebral and femoral neck fractures in postmenopausal osteoporotic patients [1, 2]. BSPs inhibit osteoclast function and induce osteoclast apoptosis, and, thus, increase bone mineral density and suppress bone turnover. However, previous studies have suggested that chronic suppression of bone turnover may produce hypermineralized bone that is more brittle, and therefore more susceptible to low-energy or stress fractures [3, 4]. Long-term BSP therapy has recently been reported to be associated with low-energy subtrochanteric and diaphyseal femoral fractures, and a peculiar, consistent fracture configuration has been described for these insufficiency fractures [5]. Radiological findings of stress reactions before the fracture have also been described [6]. Therefore, to prevent fractures, patients on long-term BSP therapy may require close monitoring. In a recent study, prophylactic fixation was performed on the basis of symptoms and radiographic findings. However, radiographic findings alone may not be sufficient to support the decision to adopt a preventive procedure. To the best of our knowledge, no study has yet been undertaken to determine whether magnetic resonance imaging (MRI) can detect cortical damage or predict an impending fracture in patients on long-term BSP therapy. In this study we used MRI to identify evidence of impending fractures in patients on long-term BSP therapy with thigh pain and a suspicious radiographic femoral lesion. …
Literature
1.
go back to reference Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85:4118–24.PubMedCrossRef Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab. 2000;85:4118–24.PubMedCrossRef
2.
go back to reference Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333:1437–43.PubMedCrossRef Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med. 1995;333:1437–43.PubMedCrossRef
3.
go back to reference Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27:687–94.PubMedCrossRef Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27:687–94.PubMedCrossRef
4.
go back to reference Ciarelli TE, Tjhia C, Rao DS, Qiu S, Parfitt AM, Fyhrie DP. Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone. 2009;45:903–8.PubMedCrossRef Ciarelli TE, Tjhia C, Rao DS, Qiu S, Parfitt AM, Fyhrie DP. Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone. 2009;45:903–8.PubMedCrossRef
5.
go back to reference Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91:2556–61.PubMedCrossRef Capeci CM, Tejwani NC. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J Bone Joint Surg Am. 2009;91:2556–61.PubMedCrossRef
6.
go back to reference Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224–31.PubMedCrossRef Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008;39:224–31.PubMedCrossRef
7.
go back to reference Koh JS, Goh SK, Png MA, Kwek EB, Howe TS. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma. 2010;24:75–81.PubMedCrossRef Koh JS, Goh SK, Png MA, Kwek EB, Howe TS. Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture? J Orthop Trauma. 2010;24:75–81.PubMedCrossRef
8.
go back to reference Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in post-menopausal women taking alendronate. N Engl J Med. 2008;358:1304–6.PubMedCrossRef Lenart BA, Lorich DG, Lane JM. Atypical fractures of the femoral diaphysis in post-menopausal women taking alendronate. N Engl J Med. 2008;358:1304–6.PubMedCrossRef
9.
go back to reference Schilcher J, Michalsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. E Engl J Med. 2011;364:1728–37.CrossRef Schilcher J, Michalsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. E Engl J Med. 2011;364:1728–37.CrossRef
10.
go back to reference Cermak K, Shumelinsky F, Alexiou J, Gebhart MJ. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy. Clin Orthop Relat Res. 2010;468:1991–6.PubMedCrossRef Cermak K, Shumelinsky F, Alexiou J, Gebhart MJ. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy. Clin Orthop Relat Res. 2010;468:1991–6.PubMedCrossRef
11.
go back to reference Rosenberg ZS, La Rocca Vieira R, Chan SS, Babb J, Akyol Y, Rybak LD, Moore S, Bencardino JT, Peck V, Tejwani NC, Egol KA. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography. AJR Am J Roentgenol. 2011;197:954–60.PubMedCrossRef Rosenberg ZS, La Rocca Vieira R, Chan SS, Babb J, Akyol Y, Rybak LD, Moore S, Bencardino JT, Peck V, Tejwani NC, Egol KA. Bisphosphonate-related complete atypical subtrochanteric femoral fractures: diagnostic utility of radiography. AJR Am J Roentgenol. 2011;197:954–60.PubMedCrossRef
12.
go back to reference Gaeta M, Minutoli F, Scribano E, Ascenti G, Vinci S, Bruschetta D, Magaudda L, Blandino A. CT and MR imaging findings in athletes with early tibial stress injuries: comparison with bone scintigraphy findings and emphasis on cortical abnormalities. Radiology. 2005;235:553–61.PubMedCrossRef Gaeta M, Minutoli F, Scribano E, Ascenti G, Vinci S, Bruschetta D, Magaudda L, Blandino A. CT and MR imaging findings in athletes with early tibial stress injuries: comparison with bone scintigraphy findings and emphasis on cortical abnormalities. Radiology. 2005;235:553–61.PubMedCrossRef
13.
go back to reference Theodorou SJ, Theodorou DJ, Resnick D. Imaging findings in symptomatic patients with femoral diaphyseal stress injuries. Acta Radiol. 2006;47:377–84.PubMedCrossRef Theodorou SJ, Theodorou DJ, Resnick D. Imaging findings in symptomatic patients with femoral diaphyseal stress injuries. Acta Radiol. 2006;47:377–84.PubMedCrossRef
14.
go back to reference Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008;93:2948–52.PubMedCrossRef Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. 2008;93:2948–52.PubMedCrossRef
Metadata
Title
Early diagnosis of impending femoral insufficiency fractures by use of MRI: case report and review of the literature
Authors
Sang-Ho Cheon
Chang-Wug Oh
Jung-Yup Lee
Jae-Hyuck Yi
Hwan-Seong Cho
Jong-Keon Oh
Kyu-Hyun Yang
Gu-Hee Jung
Publication date
01-09-2013
Publisher
Springer Japan
Published in
Journal of Orthopaedic Science / Issue 5/2013
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI
https://doi.org/10.1007/s00776-012-0218-8

Other articles of this Issue 5/2013

Journal of Orthopaedic Science 5/2013 Go to the issue